← Back to Analyst Consensus 
CRDL Buy
Cardiol Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 17, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 14, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Feb 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Dec 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jun 2, 2025 | HC Wainwright & Co. | initiate | — → Buy | $9 | 44% |
| Apr 16, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Apr 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Feb 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Dec 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Nov 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jun 26, 2024 | Roth MKM | initiate | — → Buy | $10 | 52% |
| Jun 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jun 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 23, 2024 | Canaccord Genuity | maintain | Buy → Buy | $8 | 48% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Apr 22, 2024 | HC Wainwright & Co. | initiate | — → Buy | $9 | 44% |
Price Target Trend
Jun 6, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days